Indaptus Therapeutics is trading up +5.17% at $1.22 on September 4, 2026, with no fresh company-specific announcement identified to explain the move.
- Latest notable corporate update: the August 13, 2026 second-quarter report and strategic update.
- Available September 4 search results primarily surfaced older materials.
- Broader markets are modestly lower after stronger employment data, so macro sentiment does not clearly explain the gain.